...
首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Response to the letter 'Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration
【24h】

Response to the letter 'Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration

机译:响应禁食和喂养给药后60毫克二聚石渗透性推挽系统的拜耳研究报告的拜耳研究报告的关键问题

获取原文
获取原文并翻译 | 示例
           

摘要

Sir, - We appreciate being given the opportunity to respond to the questions raised by Professor Meyer regarding the Socratec study by Anschutz et al. [1]. Some of these questions have been addressed in a separate letter by Professor Blume on behalf of Socratec. In our letter, we respond to Meyer's statements regarding the clinical relevance of the differences in formulation and dissolution behavior and the delayed absorption of Mylan's extended release nifedipine. We also address Meyer's comments regarding the clinical implications of these data.
机译:主席先生 - 我们感谢您有机会回应Meyer教授提出的关于Socratec学习的问题,Anschutz等人。 [1]。 这些问题中的一些是由Blume教授代表Socratec的单独函件。 在我们的来信中,我们回应了Meyer关于配方和溶解行为差异的临床相关性以及Mylan延伸释放硝苯地平的延迟吸收的临床相关性。 我们还涉及迈尔关于这些数据的临床意义的评论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号